Quick Links

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Lexicon Pharmaceuticals, Inc.

Oncology Briefings™: Understanding Carcinoid Syndrome Diarrhea From Diagnosis to Treatment

Release Date: June 29, 2018
Expiration Date: June 29, 2019
Media: Internet - based

Activity Overview

This activity, Oncology Briefings™: Understanding Carcinoid Syndrome Diarrhea From Diagnosis to Treatment, developed in the Physicians’ Education Resource, LLC, (PER®) established Oncology Briefings™ legacy format, is an online interactive monograph that provides an overview of recent data regarding the management of carcinoid syndrome diarrhea. This presentation features a national thought leader, Michael A. Morse, MD, who provides key insights and presents 2 patient cases with carcinoid syndrome diarrhea who were successfully treated.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Lexicon Pharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This online CME activity is directed toward oncology healthcare professionals involved in the treatment and management of carcinoid syndrome and carcinoid syndrome diarrhea, including medical oncologists, gastroenterologists, endocrinologists, and surgical oncologists. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of patients with carcinoid syndrome are also invited to participate.

Learning Objectives

Upon completion of this activity, you should be better prepared to:

  • Review the pathophysiology of neuroendocrine tumors (NETs) to stratify patients with carcinoid syndrome and its associated symptoms for optimal therapy
  • Assess current and emerging therapeutic options, as well as sequential strategies, for the treatment of patients with NETs who have carcinoid syndrome‒associated diarrhea
  • Describe the importance of a multidisciplinary approach in the management of patients with carcinoid syndrome


Michael A. Morse, MD, FACP, MHS
Duke University Medical Center
Durham, NC

Disclosure: Grant/Research Support: Ipsen, Merck, BMS; Speaker’s Bureau: Novartis, Ipsen, Merck, Lexicon, Genentech, Taiho, Celgene

The staff of Physicians’ Education Resource®, LLC, (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Become a Member

Forgot Password?
Calendar of Events
Filter By